OverviewChartNewsTraderScreen

DZ Bank Call 2.5 MDG2 19.12.2025/  DE000DQ3W0X7  /

Frankfurt Zert./DZB
2024-11-12  5:04:24 PM Chg.+0.089 Bid5:29:09 PM Ask5:29:09 PM Underlying Strike price Expiration date Option type
0.090EUR +8900.00% -
Bid Size: -		 -
Ask Size: -		 MEDIGENE AG NA O.N. 2.50 EUR 2025-12-19 Call
GlobeNewswire 08-29 Medigene AG Secures Two Additional Patents for Technologies in Its End-to-End Platform
GlobeNewswire 08-28 Medigene to Present at Upcoming Investor Conferences
GlobeNewswire 08-26 Medigene AG implements announced 2:1 share capital reduction and consolidation of the shares effecti...
GlobeNewswire 08-14 Medigene AG Reports Half-Year 2024 Financial Results and Provides Corporate Update
GlobeNewswire 08-08 Medigene AG to Report Half-Year 2024 Financial Results on August 14, 2024
GlobeNewswire 08-08 Medigene and WuXi Biologics Enter into a Research Collaboration for Off-the-Shelf TCR-Guided T Cell ...
GlobeNewswire 07-23 Medigene to Present at ESMO Congress 2024
GlobeNewswire 07-03 Medigene AG Expands Patent Portfolio with the Patent Grant for its NY-ESO-1/LAGE 1a Targeted T Cell ...
GlobeNewswire 06-27 Medigene Presents Efficient 6-Day TCR-T Therapy Production Process with High Stemness
GlobeNewswire 06-24 Medigene Reports Results of Annual General Meeting
GlobeNewswire 06-21 Medigene to Present at the Cell and Gene Therapy In-Depth Focus Summit 2024
GlobeNewswire 06-20 Medigene AG Announces Lead Selection for MDG2021, Expanding TCR-T KRAS Library Targeting Solid Tumor...
GlobeNewswire 06-11 Thermosome Appoints Dr. Sabine Hauck as Chief Technical Officer
GlobeNewswire 05-28 Medigene AG Expands its End-to-End Platform by Submitting Three Development Optimization Technology ...
GlobeNewswire 05-21 Medigene's Global Research & Collaboration Agreement with BioNTech to Extend Beyond Initially Announ...
GlobeNewswire 05-15 Medigene Presents Preclinical Data on Optimal Affinity TCRs Targeting the Neoantigen Mutant KRAS
GlobeNewswire 05-14 Medigene AG Extends Cash Runway into July 2025 After Successful Oversubscribed Capital Raise
GlobeNewswire 05-07 Medigene to Present at Upcoming Conferences
GlobeNewswire 05-06 The Benchmark Company Announces Upcoming Healthcare House Call VIRTUAL One-on-One Investor Conferenc...
GlobeNewswire 05-02 Medigene AG Expands Patent Portfolio with European Patent Grant for its NY-ESO-1 – targeted T Cell R...
GlobeNewswire 05-02 Medigene Presents Superior TCR-T Cell Functionality by Inclusion of a Costimulatory Switch Protein
GlobeNewswire 04-26 Medigene AG reports Financial Results and Business Update for Q1 2024
GlobeNewswire 04-25 Medigene presents streamlined 6-day, high stemness TCR-T therapy production process
GlobeNewswire 04-17 Medigene to Present at Upcoming Scientific Conferences
GlobeNewswire 04-08 Medigene Presents Favorable Safety Profile of TCR-T Cells with Costimulatory Switch Protein at AACR ...